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Lyme Disease, caused by the spirochete Borrelia burgdorferi and transmitted by Ixodes scapularis
(deer tick or blacklegged tick), has been gaining in incidence over the past decade. Without treat-
ment, it is a long-term infection characterized by inflammation of the joints, heart and nervous
system. The Centers for Disease Control and Prevention (CDC) classifies it as an Emerging Infec-
tious Disease with an expanding geographical area of occurrence and have recently revised their
incidence cases in the United States by 10 fold.
In this Lyme Disease Research Topic we have gathered reviews and original research in the
fields of microbiology and immunology of B. burgdorferi infection. Included in this Topic are the
abstracts from the 13th International Congress on Lyme Borreliosis and we thank the organizers
Dr. Linda Bockenstedt and Dr. Linden Hu for publishing them in this issue at the following link
http://www.frontiersin.org/books/13th_International_Conference_on_Lyme_Borreliosis_and_oth
er_tick_Borne_Diseases_/357.
Increased Geographical Distribution
As an emerging infectious disease the incidence and geographical distribution of Lyme disease
cases are being monitored by a number of US states. Based on the CDC, Ohio is considered a
non-endemic area for Lyme Disease, largely due to the low incidence of the arthropod vector
I. scapularis. A tick surveillance program established by the Ohio Department of Public Health
indicated a sharp increase in the prevalence of this tick in the state. Here, Wang et al. provide data
that suggest an establishment of the enzootic cycle in Ohio (Wang et al., 2014).
Vaccine Development—a Different Approach
The development of a Lyme disease vaccine has been a hot topic for researchers and the pub-
lic. Currently, the Food and Drug Administration has not given its approval for a human Lyme
Disease vaccine. Therefore, researchers have sought alternate approaches to address control of
B. burgdorferi infection in humans through pest management intervention. These methods have
mainly consisted of vector-targeted or reservoir-targeted vaccines aiming to reduce tick density or
control different aspects of the enzootic cycle. Gomes-Solecki writes a detailed review of the current
status of those studies (Gomes-Solecki, 2014).
Host Immunity—Novel Pathways and Genetic Approaches
Because the majority of Lyme disease pathology is due to an over-exuberant immune
response, much research in B. burgdorferi pathogenesis has been devoted to understand-
ing the mammalian host response to the bacterium. A significant focus of immune
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studies has been the innate immune response as an initiator of
inflammation. Recent studies have elucidated novel components
of the innate immune response and intracellular pathways that
participate in B. burgdorferi induced inflammation. Here, Cer-
vantes et al. and Petnicki-Ocwieja and Kern review the most
recent studies dissecting the numerous innate immune response
pathways involved in B. burgdorferi recognition (Cervantes et al.,
2014; Petnicki-Ocwieja and Kern, 2014).
Although much progress has been made in identifying
immune pathways that participate in the B. burgdorferi induced
response, it is unclear how these pathways lead to arthritis resis-
tance or susceptibility. The field of Lyme disease has long debated
the etiology of long-term inflammation and recent studies in the
murine host have shed light on relevant cell types and inflamma-
tory mediators that participate in the pathology of Lyme arthri-
tis. Pratt and Brown review the role of eicosanoids as important
mediators of arthritis (Pratt and Brown, 2014). Also, Bramwell
et al. review the challenges of genome wide association studies for
studying complex genetic traits in humans and the power of for-
ward genetic approaches in model animals leading to the identifi-
cation of genetic loci responsible for arthritis severity phenotypes
(Bramwell et al., 2014). Finally, in a research paper, Belperron
et al. present data that implicate the FcRY receptor as an impor-
tant contributor to acute phase Lyme arthritis (Belperron et al.,
2014).
Lessons from the Tick
Much of the research in Lyme Disease immunology has focused
on understanding the immune response in the mammalian host.
However, the importance of the enzootic cycle and the mode
of survival of the bacterium in its arthropod host cannot be
understated. The I. scapularis tick maintains the bacterium in its
mid-gut, but precisely how tick immunity functions and influ-
ences persistence of pathogens remains unknown. Here, Smith
and Pal discuss exciting insights that could be gained from min-
ing the sequenced Ixodes genome and highlight future areas of
investigation (Smith and Pal, 2014).
What about the Bug?
In nature, B. burgdorferi cycles between the vastly different
environments of the Ixodes tick vector and mammalian host.
B. burgdorferi must be able to detect changes in its environ-
ment, and rapidly respond to these changes. c-di-GMP, a sec-
ond messenger unique to bacteria, is a global regulator that
facilitates adaption to changing environmental circumstances.
Novak et al. provide up-to-date information on how c-di-
GMP signaling is instrumental in orchestrating the adapta-
tion of B. burgdorferi to the tick environment (Novak et al.,
2014).
Adhesion is the initial event in the establishment of any infec-
tion. B. burgdorferi modulates adhesion to host tissues in order
to colonize, disseminate, and persist in its mammalian host.
Brissette and Gaultney update current knowledge on the struc-
ture, function, and role of borrelial adhesins in Lyme disease
pathogenesis (Brissette and Gaultney, 2014).
The Next Generation: Massively Parallel
Sequencing Tnseq
B. burgdorferi lacks many traditional virulence factors, such
as toxins or specialized secretion systems. Therefore, studies
focusing on host-pathogen interactions have been limited by an
incomplete understanding of the repertoire of bacterial virulence
factors. Questions such as how the pathogen causes disease, col-
onizes the tick and evades host immune-surveillance have been
difficult to address.
Genetic studies involving single gene deletions have
identified a number of important bacterial proteins, but
a large-scale genomics approach to identify virulence fac-
tors has not been attempted until recently. Lin et al. review
the generation of a site-directed mutagenesis library as an
important step toward a detailed analysis of the B. burgdor-
feri genome and pathogenome (Lin et al., 2014). Using
this library, high-throughput genomic studies, utilizing
techniques such as massively parallel sequencing or Tnseq
have shown to be a powerful tool in understanding the
pathogen.
Lyme disease is endemic throughmuch of the Northern hemi-
sphere, including North America, Europe, and Asia, and will con-
tinue to be a public health concern for the foreseeable future. This
Topic highlights the important work that is currently being done
to understand the pathogen, the vector, and the disease. We hope
that you find this Topic as enlightening and thought-provoking
as we did.
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